RS

Reimar Schlingensiepen

AG Antisense Pharma Gmbh: 2 patents #2 of 18Top 15%
📍 Göttingen, DE: #36 of 414 inventorsTop 9%
Overall (All Time): #649,253 of 4,157,543Top 20%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
8703729 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene Karl-Hermann Schlingensiepen 2014-04-22
8629117 Method for stimulating the immune system Karl-Hermann Schlingensiepen, Wolfgang Brysch 2014-01-14
8097597 Use of low doses of oligonucleotides antisense to TGF-β genes in the treatment of brain tumors Karl-Hermann Schlingensiepen 2012-01-17
7910563 Antisense oligonucleotide to inhibit melanoma inhibitory activity, MIA Karl-Hermann Schlingensiepen 2011-03-22
7667027 Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-β (TGF-β) Georg-Ferdinand Schlingensiepen, Wolfgang Brysch, Karl-Hermann Schlingensiepen, Ulrich Bogdahn 2010-02-23
7326783 Pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms Georg-Ferdinand Schlingensiepen, Karl-Hermann Schlingensiepen, Wolfgang Brysch 2008-02-05
6455689 Antisense-oligonucleotides for transforming growth factor-&bgr; (TGF-&bgr;) Georg-Ferdinand Schlingensiepen, Wolfgang Brysch, Karl-Hermann Schlingensiepen, Ulrich Bogdahn 2002-09-24
6365345 Antisense nucleic acids for the prevention and treatment of disorders in which expression of c-erbB plays a role Wolfgang Brysch, Karl-Hermann Schlingensiepen, Georg-Ferdinand Schlingensiepen 2002-04-02